This latest FDA clearance should pave the way for the launch of the company’s Smart MDI system, which combines the InPen ...

The roughly $13 million trial is being funded by the Michigan Veteran Marijuana Research Grant Program. MAPS, a nonprofit research group based in San Jose, Calif., that is known for its work to ...

The results pave the way for our multicenter phase 2 study in DIPG ... investors sued Y-mAbs for misleading about the FDA approval. Resolving The Case To resolve the lawsuit from investors, Y-mAbs has ...

Given the large number of veterans who could use a new treatment for PTSD, a favorable study on cannabis could pave the way for more widespread ... for Psychedelic Studies said this week that the FDA ...

The new MRI standards by the IAC, effective immediately, now include portable MR scanning at the point of care.

Leaders from Ernst & Young deliver intel on the four biggest trends that impacted the medtech industry in 2024 that savvy ...

Akeso, Inc. (9926.HK)  ("Akeso" or the "Company") announced that the National Medical Products Administration (NMPA) of China has accepted its supplemental new drug application (sNDA) for penpulimab, ...

Cardiologists have expressed significant enthusiasm for deramiocel due to its potential to address a major cause of mortality in DMD patients, and its positive functional outcomes data could pave the ...

Ascentage Pharma (6855.HK) is a global, integrated biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily in ...

A drug in advanced development for myasthenia gravis also showed promise as a treatment for primary Sjögren's syndrome, a ...

Researchers used mitochondrial gene editing to model genetic disorders in mice, revealing profound impacts on brain function, ...